|
1
|
Warrow DJ, Hoang QV and Freund KB:
Pachychoroid pigment epitheliopathy. Retina. 33:1659–1672.
2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Maranduca MA, Branisteanu D, Serban DN,
Branisteanu DC, Stoleriu G, Manolache N and Serban IL: Synthesis
and physiological implications of melanic pigments. Oncol Lett.
17:4183–4187. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mrejen S and Spaide RF: Optical coherence
tomography: Imaging of the choroid and beyond. Surv Ophthalmol.
58:387–429. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lehmann M, Bousquet E, Beydoun T and
Behar-Cohen F: Pachychoroid: An inherited condition? Retina.
35:10–16. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Goldenberg D, Moisseiev E, Goldstein M,
Loewenstein A and Barak A: Enhanced depth imaging optical coherence
tomography: Choroidal thickness and correlations with age,
refractive error, and axial length. Ophthalmic Surg Lasers Imaging.
43:296–301. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Margolis R and Spaide RF: A pilot study of
enhanced depth imaging optical coherence tomography of the choroid
in normal eyes. Am J Ophthalmol. 147:811–815. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dansingani KK, Balaratnasingam C, Naysan J
and Freund KB: En face imaging of pachychoroid spectrum disorders
with sweptsource optical coherence tomography. Retina. 36:499–516.
2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang L, Jonas JB and Wei W: Choroidal
vessel diameter in central serous chorioretinopathy. Acta
Ophthalmol. 91:e358–e362. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Agrawal R, Gupta P, Tan KA, Cheung CM,
Wong TY and Cheng CY: Choroidal vascularity index as a measure of
vascular status of the choroid: Measurements in healthy eyes from a
population-based study. Sci Rep. 6(21090)2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Saito W, Hashimoto Y, Hirooka K and Ishida
S: Changes in choroidal blood flow velocity in patients diagnosed
with central serous chorioretinopathy during follow-up for
pachychoroid pigment epitheliopathy. Am J Ophthalmol Case Rep.
18(100651)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pang CE and Freund KB: Pachychoroid
neovasculopathy. Retina. 35:1–9. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sakurada Y, Fragiotta S, Leong BCS, Parikh
R, Hussnain SA and Freund KB: Relationship between choroidal
vascular hyperpermeability, choriocapillaris flow density and
choroidal thickness in eyes with pachychoroid pigment
epitheliopathy. Retina. 40:657–662. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Brănişteanu DE, Pintilie A, Andreş LE,
Dimitriu A, Oanţă A, Stoleriu G and Brănişteanu DC: Ethiopathogenic
hypotheses in lichen planus. Rev Med Chir Soc Med Nat Iasi.
120:760–767. 2016.PubMed/NCBI
|
|
14
|
Hwang H, Kim JY, Kim KT, Chae JB and Kim
DY: Flat irregular pigment epithelium detachment in central serous
chorioretinopathy: A form of pachychoroid neovasculopathy? Retina
Oct 1, 2019 (Epub ahead of print). doi:
10.1097/IAE.0000000000002662.
|
|
15
|
Imamura Y, Fujiwara T, Margolis R and
Spaide RF: Enhanced depth imaging optical coherence tomography of
the choroid in central serous chorioretinopathy. Retina.
29:1469–1473. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Demirel S, Değirmenci MFK, Batıoğlu F and
Özmert E: Evaluation of the choroidal features in pachychoroid
spectrum diseases by optical coherence tomography and optical
coherence tomography angiography. Eur J Ophthalmol.
4(1120672119887095)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Arf S, Sayman Muslubas I, Hocaoglu M,
Ersoz MG and Karacorlu M: Features of neovascularization in
pachychoroid neovasculopathy compared with type 1 neovascular
age-related macular degeneration on optical coherence tomography
angiography. Jpn J Ophthalmol. 64:257–264. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Matsumoto H, Kishi S, Mukai R and Akiyama
H: Remodeling of macular vortex veins in pachychoroid
neovasculopathy. Sci Rep. 9(14689)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bousquet E, Bonnin S, Mrejen S, Krivosic
V, Tadayoni R and Gaudric A: Tadayoni R and Gaudric A: Optical
coherence tomography angiography of flat irregular pigment
epithelium detachment in chronic central serous chorioretinopathy.
Retina. 38:629–638. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hosoda Y, Miyake M, Schellevis RL, Boon
CJF, Hoyng CB, Miki A, Meguro A, Sakurada Y, Yoneyama S, Takasago
Y, et al: Genome-wide association analyses identify two
susceptibility loci for pachychoroid disease central serous
chorioretinopathy. Commun Biol. 2(468)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Imamura Y, Engelbert M, Iida T, Freund KB
and Yannuzzi LA: Polypoidal choroidal vasculopathy: A review. Surv
Ophthalmol. 55:501–515. 2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Freund KB, Zweifel SA and Engelbert M: Do
we need a new classification for choroidal neovascularization in
age-related macular degeneration? Retina. 30:1333–1349.
2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Dansingani KK, Gal-Or O, Sadda SR,
Yannuzzi LA and Freund KB: Understanding aneurysmal type 1
neovascularization (polypoidal choroidal vasculopathy): A lesson in
the taxonomy of 'expanded spectra' - a review. Clin Exp Ophthalmol.
46:189–200. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Uyama M, Wada M, Nagai Y, Matsubara T,
Matsunaga H, Fukushima I, Takahashi K and Matsumura M: Polypoidal
choroidal vasculopathy: Natural history. Am J Ophthalmol.
133:639–648. 2002.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lee WK, Baek J, Dansingani KK, Lee JH and
Freund KB: Choroidal morphology in eyes with polypoidal choroidal
vasculopathy and normal or subnormal subfoveal choroidal thickness.
Retina. 36 (Suppl 1):S73–S82. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lee K, Park JH, Park YG and Park YH:
Analysis of choroidal thickness and vascularity in patients with
unilateral polypoidal choroidal vasculopathy. Graefes Arch Clin Exp
Ophthalmol. 258:1157–1164. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fujita A, Kataoka K, Takeuchi J, Nakano Y,
Horiguchi E, Kaneko H, Ito Y and Terasaki H: Diagnostic
characteristics of polypoidal choroidal vasculopathy based on
B-scan swept-source optical coherence tomography angiography and
its interrater agreement compared with indocyanine green
angiography. Retina: Jan 20, 2020 (Epub ahead of print). doi:
10.1097/IAE.0000000000002760.
|
|
28
|
Phasukkijwatana N, Freund KB, Dolz-Marco
R, Al-Sheikh M, Keane PA, Egan CA, Randhawa S, Stewart JM, Liu Q,
Hunyor AP, et al: Peripapillary pachychoroid syndrome. Retina.
38:1652–1667. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Govetto A, Sarraf D and Scialdone A: ‘Hide
and seek’ neurosensory retinal detachments in peripapillary
pachychoroid syndrome associated with pulmonary arterial
hypertension. Retin Cases Brief Rep: Nov 21, 2019 (Epub ahead of
print). doi: 10.1097/ICB.0000000000000942.
|
|
30
|
Branisteanu DE, Nichifor M, Dorobat CM,
Brănişteanu DC, Petrariu FD, Molodoi AD, Radu DC and Boda D: Use of
textile biomaterials for the topic treatment of chronic venous
disease. Rom Biotechnol Lett. 20:10618–10625. 2015.
|
|
31
|
Ellabban AA, Tsujikawa A, Ooto S,
Yamashiro K, Oishi A, Nakata I, Miyake M, Akagi-Kurashige Y,
Ueda-Arakawa N, Arichika S, et al: Focal choroidal excavation in
eyes with central serous chorioretinopathy. Am J Ophthalmol.
156:673–683. 2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lim FP, Wong CW, Loh BK, Chan CM, Yeo I,
Lee SY, Mathur R, Wong D, Wong TY and Cheung CM: Prevalence and
clinical correlates of focal choroidal excavation in eyes with
age-related macular degeneration, polypoidal choroidal vasculopathy
and central serous chorioretinopathy. Br J Ophthalmol. 100:918–923.
2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Rajabian F, Arrigo A, Jampol LM, Mercuri
S, Introini U, Bandello F and Battaglia Parodi M: Optical coherence
tomography angiography features of focal choroidal excavation and
the choroidal stroma variations with occurrence of excavation.
Retina: 2020 Jan 23, 2020 (Epub ahead of print). doi:
10.1097/IAE.0000000000002765.
|
|
34
|
Banaee T, Lyons LJ and El-Annan J:
Development of focal choroidal excavation in non-neovascular age
related macular degeneration with pachy-choroid features. J Curr
Ophthalmol. 31:454–457. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kitaya N, Nagaoka T, Hikichi T, Sugawara
R, Fukui K, Ishiko S and Yoshida A: Features of abnormal choroidal
circulation in central serous chorioretinopathy. Br J Ophthalmol.
87:709–712. 2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhao M, Célérier I, Bousquet E, Jeanny JC,
Jonet L, Savoldelli M, Offret O, Curan A, Farman N, Jaisser F, et
al: Mineralocorticoid receptor is involved in rat and human ocular
chorioretinopathy. J Clin Invest. 122:2672–2679. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ersoz MG, Hocaoglu M, Sayman Muslubas I,
Arf S and Karacorlu M: Development of pachychoroid pigment
epitheliopathy and transformation to central serous
chorioretinopathy after intravitreal dexamethasone implantation.
Retin Cases Brief: Sep 26, 2018 (Epub ahead of print). doi:
10.1097/ICB.0000000000000820.
|
|
38
|
Dansingani KK, Perlee LT, Hamon S, Lee M,
Shah VP, Spaide RF, Sorenson J, Klancnik JM Jr, Yannuzzi LA,
Barbazetto IA, et al: Risk alleles associated with
neovascularization in a pachychoroid phenotype. Ophthalmology.
123:2628–2630. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Izumi T, Koizumi H, Maruko I, Takahashi Y,
Sonoda S, Sakamoto T and Iida T: Structural analyses of choroid
after half-dose verteporfin photodynamic therapy for central serous
chorioretinopathy. Br J Ophthalmol. 101:433–437. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Chhablani J, Kozak I, Pichi F, Chenworth
M, Berrocal MH, Bedi R, Singh RP, Wu L, Meyerle C, Casella AM, et
al: King Khaled Eye Specialist Hospital International Collaborative
Retina Study Group: Outcomes of treatment of choroidal
neovascularization associated with central serous chorioretinopathy
with intravitreal antiangiogenic agents. Retina. 35:2489–2497.
2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Staurenghi G, Lai TYY, Mitchell P, Wolf S,
Wenzel A, Li J, Bhaumik A and Hykin PG: PROMETHEUS Study Group.
Efficacy and Safety of Ranibizumab 0.5 mg for the treatment of
macular edema resulting from uncommon causes. Twelve-month findings
from PROMETHEUS. Ophthalmology. 125:850–862. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Chung YR, Seo EJ, Lew HM and Lee KH: Lack
of positive effect of intravitreal bevacizumab in central serous
chorioretinopathy: Meta-analysis and review. Eye (Lond).
27:1339–1346. 2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Schworm B, Luft N, Keidel LF, Hagenau F,
Kern C, Herold T, Kortuem KU, Priglinger SG and Siedlecki J:
Response of neovascular central serous chorioretinopathy to an
extended upload of anti-VEGF agents. Graefes Arch Clin Exp
Ophthalmol. 258:1013–1021. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Sacconi R, Tomasso L, Corbelli E,
Carnevali A, Querques L, Casati S, Bandello F and Querques G: Early
response to the treatment of choroidal neovascularization
complicating central serous chorioretinopathy: A OCT-angiography
study. Eye (Lond). 33:1809–1817. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Azuma K, Tan X, Asano S, Shimizu K, Ogawa
A, Inoue T, Murata H, Asaoka R and Obata R: The association of
choroidal structure and its response to anti-VEGF treatment with
the short-time outcome in pachychoroid neovasculopathy. PLoS One.
14(e0212055)2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lee JH and Lee WK: One-year results of
adjunctive photodynamic therapy for type 1 neovascularization
associated with thickened choroid. Retina. 36:889–895.
2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y,
Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, et al: EVEREST
study: Efficacy and safety of verteporfin photodynamic therapy in
combination with ranibizumab or alone versus ranibizumab
monotherapy in patients with symptomatic macular polypoidal
choroidal vasculopathy. Retina. 32:1453–1464. 2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Shin JY, Kwon KY and Byeon SH: Association
between choroidal thickness and the response to intravitreal
ranibizumab injection in age-related macular degeneration. Acta
Ophthalmol. 93:524–532. 2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Baek J, Lee JH and Lee WK: Clinical
relevance of aqueous vascular endothelial growth factor levels in
polypoidal choroidal vasculopathy. Retina. 37:943–950.
2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Saito M, Kano M, Itagaki K, Ise S,
Imaizumi K and Sekiryu T: Subfoveal choroidal thickness in
polypoidal choroidal vasculopathy after switching to intravitreal
aflibercept injection. Jpn J Ophthalmol. 60:35–41. 2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Cho HJ, Kim KM, Kim HS, Han JI, Kim CG,
Lee TG and Kim JW: Intravitreal aflibercept and ranibizumab
injections for polypoidal choroidal vasculopathy. Am J Ophthalmol.
165:1–6. 2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Koizumi H, Kano M, Yamamoto A, Saito M,
Maruko I, Kawasaki R, Sekiryu T, Okada AA and Iida T: Short-term
changes in choroidal thickness after aflibercept therapy for
neovascular age-related macular degeneration. Am J Ophthalmol.
159:627–633. 2015.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Ferrara N: Vascular endothelial growth
factor: Basic science and clinical progress. Endocr Rev.
25:581–611. 2004.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Yong M, Zhou M and Deng G: Photodynamic
therapy versus anti-vascular endothelial growth factor agents for
polypoidal choroidal vasculopathy: A meta-analysis. BMC Ophthalmol.
15(82)2015.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Stanca HT, Petrović Z and Munteanu M:
Transluminal Nd:YAG laser embolysis - a reasonable method to
reperfuse occluded branch retinal arteries. Vojnosanit Pregl.
71:1072–1077. 2014.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Munteanu M, Rosca C and Stanca H:
Sub-inner limiting membrane hemorrhage in a patient with Terson
syndrome. Int Ophthalmol. 39:461–464. 2019.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Stanca HT, Stanca S, Tabacaru B, Boruga M
and Balta F: Bevacizumab in Wet AMD treatment: A tribute to the
thirteen years of experience from the beginning of the anti-VEGF
era in Romania. Exp Ther Med. 18:4993–5000. 2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Danielescu C, Stanca HT and Balta F: The
management of lamellar macular holes: A review. J Ophthalmol.
2020(3526316)2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Shin JY, Lee JM and Byeon SH:
Anti-vascular endothelial growth factor with or without pneumatic
displacement for submacular hemorrhage. Am J Ophthalmol.
159:904–14.e1. 2015.PubMed/NCBI View Article : Google Scholar
|
